B. Metzler seel. Sohn & Co. Holding AG Takes $1.15 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

B. Metzler seel. Sohn & Co. Holding AG bought a new stake in The Cooper Companies, Inc. (NASDAQ:COO) during the 3rd quarter, HoldingsChannel reports. The fund bought 10,456 shares of the medical device company’s stock, valued at approximately $1,154,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. LRI Investments LLC raised its stake in shares of Cooper Companies by 4.5% in the second quarter. LRI Investments LLC now owns 2,595 shares of the medical device company’s stock valued at $227,000 after acquiring an additional 112 shares during the period. Mitchell & Pahl Private Wealth LLC grew its holdings in shares of Cooper Companies by 1.5% in the third quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company’s stock worth $881,000 after purchasing an additional 117 shares during the last quarter. Commonwealth Equity Services LLC grew its holdings in shares of Cooper Companies by 0.8% in the second quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock worth $1,362,000 after purchasing an additional 118 shares during the last quarter. Bleakley Financial Group LLC grew its holdings in shares of Cooper Companies by 2.1% in the third quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company’s stock worth $636,000 after purchasing an additional 119 shares during the last quarter. Finally, First Horizon Advisors Inc. grew its holdings in shares of Cooper Companies by 4.8% in the second quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock worth $236,000 after purchasing an additional 125 shares during the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Insider Activity at Cooper Companies

In related news, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the completion of the transaction, the chief accounting officer now directly owns 4,818 shares of the company’s stock, valued at $520,488.54. This trade represents a 24.94 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Brian G. Andrews sold 24,788 shares of the stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the transaction, the chief financial officer now directly owns 6,614 shares of the company’s stock, valued at $700,422.60. The trade was a 78.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 256,373 shares of company stock valued at $27,637,427 in the last three months. 2.00% of the stock is owned by insiders.

Cooper Companies Stock Up 0.9 %

NASDAQ:COO opened at $100.80 on Friday. The Cooper Companies, Inc. has a fifty-two week low of $82.21 and a fifty-two week high of $112.38. The stock has a market capitalization of $20.07 billion, a P/E ratio of 56.00, a P/E/G ratio of 2.15 and a beta of 0.99. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The company’s 50-day simple moving average is $105.91 and its 200-day simple moving average is $98.29.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. During the same period last year, the business earned $0.84 EPS. The company’s revenue was up 7.8% compared to the same quarter last year. On average, equities analysts anticipate that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

COO has been the topic of a number of research analyst reports. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Stifel Nicolaus restated a “buy” rating and issued a $115.00 price target (up from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Robert W. Baird increased their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Finally, Wells Fargo & Company increased their target price on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.